Litcius/Paper detail

Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab

Alexander Kroemer, Leonid Belyayev, Karim Khan, Katrina Loh, Ji‐Man Kang, Anju Duttargi, Harmeet Dhani, Mohammed Sadat, Oswaldo Aguirre, Yuriy Gusev, Krithika Bhuvaneshwar, Bhaskar Kallakury, Christopher Cosentino, Brenna Houlihan, Jamie Diaz, Sangeetha Moturi, Nada Yazigi, Stuart S. Kaufman, Sukanya Subramanian, Jason Hawksworth, R. Girlanda, Simon C. Robson, Cal Matsumoto, Michael Zasloff, Thomas Fishbein

2020American Journal of Transplantation34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInfliximabImmunityImmunologyTumor necrosis factor alphaImmune systemClinical Nutrition and GastroenterologyImmune Cell Function and InteractionImmune responses and vaccinations
Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab | Litcius